R&G PharmaStudies Co (SZSE:301333) Change In Payables And Accrued Expense : ¥0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is R&G PharmaStudies Co Change In Payables And Accrued Expense?

R&G PharmaStudies Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means R&G PharmaStudies Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

R&G PharmaStudies Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0.0 Mil. It means R&G PharmaStudies Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

R&G PharmaStudies Co Change In Payables And Accrued Expense Historical Data

The historical data trend for R&G PharmaStudies Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

R&G PharmaStudies Co Change In Payables And Accrued Expense Chart

R&G PharmaStudies Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

R&G PharmaStudies Co Quarterly Data
	Dec17	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

R&G PharmaStudies Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

R&G PharmaStudies Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of R&G PharmaStudies Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

R&G PharmaStudies Co (SZSE:301333) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » R&G PharmaStudies Co Ltd (SZSE:301333) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 518, Chuangyi West Road, East District, Economic Development Zone, Tongzhou District, Beijing, CHN, 100048

Website

R&G PharmaStudies Co Ltd is a clinical trial outsourcing service provider. It offers full-chain clinical research outsourcing services, serving global pharmaceutical and medical device companies and scientific research institutions.

R&G PharmaStudies Co (SZSE:301333) Headlines

No Headlines